Arrowhead Research reported $-64883000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agios Pharmaceuticals AGIO:US $ -91152000 70K
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Anika Therapeutics ANIK:US $ 2.76M 8.63M
Arena Pharmaceuticals ARNA:US $ -124485000 19.91M
Arrowhead Research ARWR:US $ -64883000 33.02M
Bluebird Bio BLUE:US $ -196779000 44.06M
Cerulean Pharma CERU:US $ -12668940 3.51M
Dicerna Pharmaceuticals DRNA:US $ -20272000 19.97M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Ligand Pharmaceuticals LGND:US $ 15.71M 30.03M
Merk MRK:US $ 5352M 3083M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Moderna Inc MRNA:US 3.56B 496M
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Novartis NOVN:VX 3.48B 77M
Opko Health OPK:US $ 6.32M 747K
Sarepta Therapeutics SRPT:US $ -34458000 133.12M
Spectrum Pharmaceuticals SPPI:US $ -33093000 10.98M
Tg Therapeutics TGTX:US $ -85128000 7.64M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
Xencor XNCR:US $ -41300000 50.39M
YTE INCY:US $ 247.47M 92.16M